Selective Bromination of 4-Chloro-1-indanone and Synthesis of (4-Chloro-2, 3-Dihydro-1H-indene-2-yl)methanamine by Jasouri, S et al.
Selective Bromination of 4-Chloro-1-indanone
and Synthesis of
(4-Chloro-2, 3-Dihydro-1H-indene-2-yl)methanamine
S. Jasouri1,2, J. Khalafy1,*, M. Badali2 and M. Piltan1
1Department of Chemistry, Urmia University, Urmia 57154, Iran.
2Daana Pharmaceutical Co., P.O. Box 5181-51575, Tabriz, Iran.
Received 23 June 2010, Revised 10 July 2010, Accepted 12 July 2010.
ABSTRACT
The synthesis of 4-chloro-1-indanone in four steps from 2-chlorobenzaldehyde was investigated. Bromination of this compound
under various conditions occurred in the cyclopentanone ring, producing mono- and dibromo derivatives. Cyanation of
2-bromo-4-chloro-1-indanone followed by reduction gave (4-chloro-2, 3-dihydro-1H-indene-2-yl)methanamine in quantitative
yield.
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1. Introduction
The preparation of 4-chloro-1-indanone (5) as starting material
for the synthesis of some potential anti-Parkinson’s disease
drugs is of interest to the pharmaceutical industry, and has
been prepared by a number of workers by the cyclization of
3-(2-chlorophenyl)propionic acid.1–6
Selective bromination of this compound on the cyclo-
pentanone ring would give useful intermediates in C-C bond
formation via metal-catalysed cross coupling reactions for the
synthesis of pharmaceuticals and agrochemicals.7,8 A variety of
bromination protocols have been developed and reported for
the bromination of aromatic systems.9–19 Herein we report the
synthesis and selective α-bromination of 4-chloro-1-indanone.
We propose to use this molecule, and other indanones, as inter-
mediates to synthesize potential binders for GABAB receptors.
GABAB receptors are of considerable significance, being
involved in a number of important physiological processes, such
as autonomic function, memory and cognition, as well as motor
and sensory control.20,21
In previous work,22,23 we outlined the working hypothesis
(Fig. 1) for the structural requirements of possible GABAB recep-
tor modulators. The conformation mobility of the arylpropyl-
amine moiety spacer group could be restrained if it were part of
an indanylethylamine group, as in structure 9. Hence, the syn-
thesis of intermediate compounds of type 9 was an important
requirement for further study.
2. Results and Discussion
3-(2-Chlorophenyl)propanoic acid (3) was cyclized to
4-chloro-1-indanone (5) by refluxing the corresponding acid
chloride (4) in the presence of aluminum chloride in dichloro-
methane (Scheme 1).
This compound was then brominated in a number of solvents,
with and without acid or base catalysts. The results are shown in
Table 1. When compound 5 was reacted with Br2 in CCl4 or CHCl3
at room temperature, 2,2-dibromo-4-chloro-1-indanone (6) was
obtained as the major product in 40 % yield, along with recov-
ered starting material. In the 1HNMR spectrum of 6 the two C3
proton signals were identified as a singlet at δ 4.26 ppm. The
mass spectrum showed the required molecular ions for a
dibrominated product. The desired selective monobromination
at C-2 was achieved using bromine in diethyl ether or in acetic
acid at room temperature. Oxidative bromination of 5 in an
aqueous H2O2-HBr system also gave monobrominated product
7, but in only 42 % yield. The reaction of 5 and Br2/K2CO3
in CH2Cl2 at room temperature for 1 h gave a mixture of
compounds 6 and 7 in the ratio of 1:5, but at 0 °C only 7 was
obtained in 45 % yield (Scheme 2).
Selective monobromination was quite difficult to control. Thus
bromination in CCl4 at 0 °C gave low yields of mono brominated
product, but under the same conditions (1 eq Br2) at 25 °C only
the 2,2-dibrominated indanone could be isolated. Relatively
polar conditions to were necessary to achieve high yields of
monobrominated material in acetic acid at 25 °C. The presence of
base (solid KOH or K2CO3) encouraged the formation of
dibrominated product, presumably because the monobromo
compound 7 was more readily enolized than the indanone (5).
2-Cyano-4-chloro-1-indanone (8) was synthesized from 7 by
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Figure 1 Proposed active site for 3-arylpropyl-α-methylbenzylamines.
reaction with sodium cyanide. The optimal procedure was to
react 7 with sodium cyanide in EtOH/H2O.
15 The FT-IR spectrum
of this compound showed the peak for the CN group at
2213 cm–1. The structure of 8 was confirmed by 1HNMR and
13CNMR spectroscopy. Hydrogenation with H2/Pd-C in
MeOH/HCl and neutralization with ammoniacal chloroform
gave (4-chloro-2,3-dihydro-1H-indene-2-yl)methanamine (9) in
75 % yield (Scheme 3).24 The FT-IR spectrum of this product
showed the NH2 group at 3412 cm
–1 and lacked any signals attrib-
utable to carbonyl and nitrile groups.
To what extent this compound, and similar analogues, are
useful for the synthesis of compounds that mimic or antagonize
the effects of baclofen25 (10) and fendiline26 (11) awaits further
study.
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Scheme 1
Table 1 Bromination of 4-chloro1-indanone a (1 eq) (5).
Reaction conditions Major product yield/%
Br2 (1 eq) / CCl4 / rt / 2 h
9 6 40
Br2 (1 eq) / CCl4 / ice bath / 2 h
9 7 25
Br2 (1 eq) / diethyl ether
14,15 7 90
Br2 (1 eq) / AlCl3 / CH2Cl2 / ice bath / 2 h
9 No reaction –
H2O2 (2 eq) / H2O (1.3 mL) / HBr (48 % aqueous, 1 eq) / dark / rt / 24 h
10,11 7 42
NBS (1 eq) / H2O (26 mL) / H2SO4 (40 % aqueous solution, 1 eq) / 60 °C / 5 h
12 No reaction –
NBS (1 eq) / PTSA (0.1 eq) / 60 °C / 10 min12 No reaction –
NBS (1eq) / H2O (1.3 mL) / 100W / 15 h
9 No reaction –
Br2 (1 eq) / AcOH / rt / 2 h
9 7 73
Br2 (2 eq) / K2CO3 (3 eq) / CH2Cl2 / rt / 1 h
9 Di:Mono (1:5) 60
Br2 (2 eq) / K2CO3 (3 eq) / CH2Cl2 / ice bath / 1 h
9 7 45
Br2 (2 eq) / KOH (3 eq) / CH2Cl2 / ice bath / 1 h
9 No reaction –
Br2 (2 eq) / KOH (3 eq) / CH2Cl2 / rt / 1 h
9 Several products –




General: 1HNMR (300 MHz) and 13CNMR (75 MHz) spectra
were recorded in CDCl3 on a Bruker spectrometer. Chemical
shifts (δ) are in parts per million (ppm) relative to tetramethyl
silane, and coupling constants (J) are given in Hertz. Infrared
spectra were recorded on a Bruker FT-IR spectrometer using KBr
disks. Mass spectra were recorded on an Agilent 6890-network-
GC system. Melting points were determined on a Philips Harris
C4954718 apparatus. Analytical thin-layer-chromatography
(TLC) was carried out with Merck silica gel 60 F254λ aluminum
sheets. Hydrogenation was carried out by using Varian Aero-
graph - 9225, hydrogen generator. The routine purification of
reagents and solutions was carried out by standard laboratory
procedures. All organic extracts were dried with anhydrous
sodium sulphate.
3.1. Preparation of 4-Chloroindane-1-one
3.1.1. (E)-3(2-chlorophenyl) acrylic acid (2). 2-Chlorobenz-
aldehyde (28.10 g, 200.0 mmol), acetic anhydride (30.00 g,
294.0 mmol) and freshly fused finely powdered potassium ace-
tate (12.00 g, 122.0 mmol) were heated in an oil bath at 160 °C for
one hour and at 180 °C for a further 3 hours. While still hot, the
mixture was poured into water (100 mL), and saturated aqueous
sodium carbonate was added until the mixture was alkaline. The
solution was steam distilled to remove excess reagent, cooled
and filtered. The filtrate was acidified with concentrated hydro-
chloric acid, cooled, and the 2-chlorocinnamic acid collected and
recrystallized from water to give compound 2 as white crystals
(26.3 g, 72 %), m.p. 205–207 °C.
1HNMR(CDCl3): δ (ppm) 6.50 (d, J = 16 Hz, 1 H), 7.36 (t, J =
7.5 Hz, 1 H, ArH), 7.38 (t, J = 7.5 Hz, 1 H, ArH), 7.49 (d, J = 7.8 Hz,
1 H, ArH), 7.71 (d, J = 7.5 Hz, 1 H, ArH), 8.26 (d, J = 16 Hz, 1 H),
10.4 (bs, 1 H, CO2H);
13CNMR (CDCl3): δ (ppm) 39.9, 63.8, 121.7,
127.1, 127.6, 130.0, 130.9, 140.0, 168.1; FT-IR νmax (cm
–1) 2836, 1686,
1622, 1470, 1441, 1337, 1286, 1038, 984, 756, 735, 598 and m/z
184(M+), 182, 147, 103, 101, 91.
3.1.2. 3-(2-Chlorophenyl) Propanoic Acid (3). (E)-3(2-chloro-
phenyl) acrylic acid (1.00 g, 5.5 mmol) was dissolved in dried and
preheated ethyl acetate (100 mL), 10 % Pd-C (0.05 g) was added,
and the mixture was then hydrogenated at room temperature.
Hydrogenation was carried out with stirring under hydrogen
for 15 hours at atmospheric pressure. The suspension was
filtered and the solvent removed to yield 3-(2-chlorophenyl)
propanoic acid (3) as colourless needles (0.93 g, 92 %), m.p.
80–82 °C.
1HNMR(CDCl3): δ (ppm) 2.71 (t, J = 7.8 Hz, 2 H), 3.08 (t, J =
7.8 Hz, 2 H), 7.18–7.33 (m, 4 H, ArH), 10.5 (1 H, bs, CO2H);
13CNMR (CDCl3): δ (ppm) 28.1, 33.2, 126.4, 127.4, 129.1, 129.9,
133.4, 137.1, 178.8 ; FT-IR(KBr) νmax (cm
–1) 2921, 1698, 1475, 1443,
1322, 1271, 1061, 1033, 933, 786, 751, 710, 665, 581 and m/z
186(M+), 184, 167, 149, 138, 125, 103, 89, 77.
3.1.3. 4-Chloro-1-indanone (5). A mixture of thionylchloride
(3.60 g, 30.0 mmol), carbon tetrachloride (20 mL) and
3-(2-chlorophenyl) propanoic acid (3) (4.60 g, 25.0 mmol) was
refluxed for three hours. Removal of the solvent gave
3-(2-chlorophenyl) propanoyl chloride (4) as a colourless oil
(4.3 g, 85 %).
The acid chloride (4) (4.30 g, 21.0 mmol) was dissolved in di-
chloromethane (20 mL) and freshly sublimed aluminum chlo-
ride (3.10 g, 23.0 mmol) added. The reaction mixture was
refluxed for 8 hours. After cooling, the aluminum chloride com-
plex was decomposed with crushed ice (10 g) and concentrated
hydrochloric acid (2.5 mL). The mixture was extracted with
dichloromethane, which was washed with 10 % sodium hydrox-
ide (2 mL) and water (3 mL) and dried over anhydrous sodium
sulphate. Removal of the solvent gave the desired product as
pale yellow crystals (3.34 g, 93 %), m.p. 90–92 °C.
1HNMR (CDCl3): δ (ppm) 2.74 (t, J = 6.1 Hz, 2 H), 3.15 (t, J =
6.1 Hz, 2 H), 7.35 (dd, J1 = 7.7 Hz, J2 = 7.6 Hz, 1 H, ArH), 7.60 (d, J =
7.7 Hz, 1 H, ArH), 7.68 (d, J = 7.6 Hz, 1 H, ArH); 13CNMR (CDCl3):
δ (ppm) 25.27, 36.40, 122.41, 129.29, 133.27, 134.52, 139.38, 152.97,
206.19; FT-IR νmax (cm
–1) 3066, 2925, 1707, 1598, 1428, 1325, 1261,
1133, 1037, 788, 610 and m/z 168(M++2), 166(M+), 149(100),
138,125, 103, 77, 63, 51.
Using boron trifluride in acetonitrile instead of aluminium
trichloride in dichloromethane under the above conditions gave
the cyclized product in 95 % yield.
3.2. Bromination of 4-Chloro-1-indanone (5)
3.2.1. With bromine/CCl4 at room temperature. Bromine
(1.3 mL, 2.6 mmol) was added to a solution of 5 (0.43 g, 2.6 mmol)
in CCl4 (35 mL) at room temperature with the exclusion of light.
After 2 hours, excess bromine and CCl4 were removed, the
residue was neutralized with 10 % NaOH and extracted with
dichloromethane. The extract was then dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by
recrystallization from n-hexane to give 2,2-dibromo-4-chloro-
1-indanone (6) as pale yellow crystals (0.34 g, 40 %), m.p.
73–74 °C.
1HNMR (CDCl3): δ (ppm) 4.26 (s, 2 H, CH2), 7.49 (dd, J1 = 7.8 Hz,
J2 = 7.5 Hz, 1 H, ArH), 7.72 (d, J = 7.5 Hz, 1 H, ArH), 7.85 (d, J =
7.8 Hz, 1 H, ArH); 13CNMR (CDCl3): δ (ppm) 51.19, 55.30, 124.78,
130.47, 131.01, 132.20, 136.39, 144.86, 185.16; FT-IR(KBr) νmax (cm
–1)
1740, 1598, 1461, 1259, 1133, 956, 813, 705, 596 and m/z
328(M++6), 326(M++4), 324(M++2), 322(M+), 247, 245(100), 243,
164, 136, 102, 99, 75.
3.2.2. With Bromine/CCl4 at 0 °C. The above procedure at 0 °C
yielded 2-bromo-4-chloro-1-indanone (7) as the main product
(0.16 g, 25 %), m.p. 64–65 °C.
1HNMR (CDCl3): δ (ppm) 3.43 (dd, J1 = 18.6 Hz, J2 = 7.5 Hz, 1 H,
CH2), 3.84 (dd, J1 = 18.6 Hz, J2 = 3 Hz, 1 H, CH2), 4.68 (dd , J1 =
7.5 Hz, J2 = 3 Hz, 1 H, CH), 7.43 (dd, J1 = 7.8 Hz, J2 = 7.5 Hz, 1 H,
ArH), 7.68 (d, J = 7.8 Hz, 1 H, ArH),7.77 (d, J = 7.5 Hz, 1 H, ArH);
13CNMR (CDCl3): δ (ppm) 51.17, 55.37, 124.77, 130.51, 130.98,
132.19, 136.41, 144.82, 191.92; FT-IR(KBr) νmax (cm
–1) 1724, 1597,
1460, 1337, 1262, 864, 753, 688 and m/z 248, 246, 244, 165(100), 137,
102, 75.
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Increasing the reaction time to six hours gave a mixture of
dibromo and monobromo indanones in a 3:1 ratios, respectively,
with no sign of any starting material left.
3.2.3. With bromine/CHCl3 at room temperature. The above
procedure with CHCl3 as solvent, at room temperature, gave 6
in 40 % yield (0.34 g). When this method was carried out with a
2:1 molar ratio of Br2: 5, the yield was increased to 0.57 g (68 %).
3.2.4. With bromine/CHCl3 at 0 °C. Essentially unreacted start-
ing materials were recovered under the conditions of 2.3 at 0 °C.
3.2.5. With bromine/diethyl ether. To a solution of 4-chloro-
1-indanone (5) (2.00 g, 12.0 mmol) in 200 mL anhydrous diethyl
ether was added one drop of bromine from 0.6 mL, (12.0 mmol)
and the solution, which decolourized rapidly, was then cooled to
10 °C. The remaining bromine was added slowly over a ten-
minute period, allowing each drop of bromine to decolourize
before more was added. The mixture was then swirled at room
temperature until the yellow, insoluble addition complex which
had formed, was completely dissolved. After pouring into ice
water, the ether layer was washed with water and dilute sodium
bicarbonate, and then evaporated. Recrystallization of the
residue from light petroleum or benzene gave 7 (2.60 g, 90 %).
3.2.6. With an aqueous H2O2-HBr system. 4-Chloro-1-indanone
(5) (0.43 g, 2.6 mmol) was added to a mixture of water (1.30 mL),
48 % aqueous HBr (0.30 mL, 2.6 mmol) and 30 % H2O2 (0.53 mL,
5.2 mmol). The reaction mixture was stirred at room temperature
in the dark. After 24 h, the reaction mixture was dissolved in
hexane/ethyl acetate (20:1,13 mL) and solid NaHSO3 added to
neutralize any unreacted HBr or H2O2. The solution was then
dried over anhydrous Na2SO4 and evaporated under reduced
pressure to give 7 (0.27 g, 42 %).
3.2.7. With Bromine/AcOH at room temperature. Bromine
(1.43 mL, 2.86 mmol) was added dropwise to a solution of 5
(0.43 g, 2.6 mmol) in CCl4 (35 mL) and acetic acid (40 mL). The
solution was stirred for 2 hours at room temperature, then
poured into water and treated with 5 % sodium bisulphite
solution. The product was filtered, washed with water and
recrystallized from methanol to give 7 (0.464 g, 73 %).
3.2.8. With Bromine/K2CO3 at room temperature. Bromine
(1.52 mL, 1.0 mmol) was added, with the exclusion of light, to
mixture of 5 (0.09 g, 0.5 mmol) and K2CO3 (0.21 g, 1.6 mmol) in
CH2Cl2 (20 mL) at room temperature. After 1 h the reaction was
quenched with 1 M Na2S2O3 and extracted with CH2Cl2, dried
over anhydrous Na2SO4 and evaporated to give a mixture of
mono- and dibromo products in the ratio of 5:1 (60 %).
3.2.9. With Bromine/K2CO3 at 0 °C. The procedure described in
section 2.8 was followed, but with cooling in an ice-bath to give 7
(0.06 g, 45 %).
3.2.10. With Bromine/KOH at room temperature. The procedure
described in section 2.8 was followed with KOH as base, but
yielded a mixture of products, which was not further character-
ized.
3.3. Cyanation of 2-Bromo-4-chloro-1-indanone (7)
A solution of 2-bromo-4-chloro-1-indanone (7) (2.40 g,
10.0 mmol) and sodium cyanide (4.9 g, 100.0 mmol) in ethanol
(70 mL) and water (5 mL) was refluxed for 25 minutes. After cool-
ing, the solution was diluted with water, extracted twice with
ether, and the chilled aqueous phase acidified with cold HCl.
The oily cyanoketone was extracted with chloroform, and the
solution clarified with Norite and then extracted with small por-
tions of 5 % KOH until a test portion no longer gave a precipitate
on acidification. Acidification of the combined cold aqueous lay-
ers gave 2-cyano-4-chloro-1-indanone (8) as a white powder
(1.36 g, 71 %), m.p. 112–114 °C.
1HNMR (CDCl3) δ (ppm): 3.44 (dd, J1 = 11.4 Hz, J2 = 4.8 Hz, 1
H), 3.66 (dd, J1 = 11.4 Hz, J2 = 8.7 Hz, 1 H), 3.77 (dd, J1 = 8.7 Hz,
J2 = 4.8 Hz, 1 H), 7.47 (dd, J1 = 7.8 Hz, J2 = 7.5 Hz, 1 H, ArH), 7.71
(d, J = 7.5 Hz, 1 H, ArH), 7.83 (d, J = 7.8 Hz, 1 H, ArH); 13CNMR
(CDCl3): δ (ppm) 30.23, 36.86, 116.21, 123.48, 130.25, 132.90,
135.83, 135.96, 149.07, 193.88; FT-IR(KBr) νmax (cm
–1) 3112, 2213,
1617, 1593, 1294, 788, 716 and m/z 193(M++2), 191(M+), 164, 128,
119(100), 91, 43.
3.4. Hydrogenation of Indanone (8)
A mixture of 8 (0.73 g, 3.8 mmol), methanol (38 mL), concen-
trated HCl (0.60 mL), and 10 % palladium on carbon (0.50 g) was
stirred under an atmosphere of hydrogen at 25 °C and atmo-
spheric pressure for 20 h. The mixture was filtered through
Celite, and the solvent removed to give 0.85 g (96 %) of the
hydrochloride salt of 9. This was suspended in chloroform,
cooled to 0 °C, and treated with excess 1 % ammoniacal chloro-
form*. The precipitated ammonium chloride was removed by
filtration and the solvent removed to give (4-chloro-2,3-
dihydro-1H-indene-2-yl)methanamine (9) as a white powder
(0.59 g, 86 %), m.p. 98–100 °C.
1HNMR (CDCl3): δ ( ppm) 1.61 (bs, 2 H, NH2), 2.50–2.59 (m, 1 H,
CH), 2.68 (dd, J1 = 15.6 Hz, J2 = 6.9 Hz, 2 H, C-1), 2.81 (d, J =
6.9 Hz, 2 H, *CH2-NH2), 3.10 (dd, J1 = 15.6 Hz, J2 = 7.5 Hz, 2 H,
C-3),7.27–7.09 (m, 3 H, ArH); 13CNMR (CDCl3): δ (ppm) 36.80,
40.81, 45.13, 46.55, 124.85, 125.15, 126.45, 143.02, 143.27, 158.23;
FT-IR(KBr) νmax (cm
–1) 3393, 2925, 1577, 1288, 744 and m/z
183(M++2), 181(M+), 164, 129(100), 115, 91, 44.
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